{"id":1878,"date":"2009-10-01T01:00:00","date_gmt":"2009-10-01T00:00:00","guid":{"rendered":"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/"},"modified":"2018-10-20T18:39:51","modified_gmt":"2018-10-20T16:39:51","slug":"adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab","status":"publish","type":"post","link":"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/","title":{"rendered":"Ad\u00e9nocarcinome colique et ad\u00e9nopathies envahies : un cancer peut en cacher un autre ! \u00e0 propos d\u2019un cas de lymphome sous Adalimumab*"},"content":{"rendered":"<p><strong>2009<\/strong><\/p>\n<p><em>Vincent Gilles (1), Faiza Khemissa-Akouz (1), Andr\u00e9-Jean Remy (1), St\u00e9phane Ollivier (1), Sofiane Dahmouni(1), Claire Scotto (2), Bernard Heran (1).<br \/>\n(1)\tService d\u2019H\u00e9patogastroent\u00e9rologie et de Canc\u00e9rologie Digestive<br \/>\n(2)\tService de Rhumatologie<br \/>\nCentre Hospitalier de Perpignan<\/em><\/p>\n<p><strong>Gastroent\u00e9rologie <\/strong>&#8211; \u00a02009-07-08 &#8211;\u00a0CO &#8211;<\/p>\n<p>________________________________<\/p>\n<p>Plusieurs d\u00e9sordres lymphoprolif\u00e9ratifs apparus chez les patients trait\u00e9s par immunosuppresseurs ont \u00e9t\u00e9 ces derni\u00e8res ann\u00e9es sujet \u00e0 controverse. Nous rapportons le cas ici d\u2019une femme pr\u00e9sentant une polyarthrite rhumatoide trait\u00e9e par m\u00e9thotrexate et adalimumab et chez qui a \u00e9t\u00e9 d\u00e9couvert une n\u00e9oplasie colique et un lymphome lymphocytique.<\/p>\n<p>Une femme n\u00e9e en 1938 \u00e9tait suivie par le service de rhumatologie pour polyarthrite rhumato\u00efde \u00e9voluant depuis 20 ans trait\u00e9e par diff\u00e9rentes lign\u00e9es th\u00e9rapeutiques : sels d\u2019or, salazopyrine, et Methotrextate \u00e0 la dose de 7,5 mg par semaine introduit en avril 2002. Une corticoth\u00e9rapie \u00e9tait toujours maintenue \u00e0 doses modul\u00e9es. En Mars 2005, du fait des persistances des sympt\u00f4mes inflammatoires, la d\u00e9cision \u00e9tait prise de d\u00e9buter un traitement par anti-TNF alpha de type Adalimumab \u00ab Humira \u00bb \u00e0 la dose de 40 mg toutes les 2 semaines. Un tr\u00e8s bon contr\u00f4le clinique et biologique \u00e9tat alors obtenu.<br \/>\nEn 2008, dans le cadre d\u2019une campagne de d\u00e9pistage par Hemocult II, une coloscopie d\u00e9couvrait une tumeur colique gauche ad\u00e9nocarcinomateuse. La tomodensitom\u00e9trie ne montrait pas de m\u00e9tastases \u00e0 distance mais plusieurs ad\u00e9nopathies r\u00e9trop\u00e9riton\u00e9ales et m\u00e9sent\u00e9riques. Une geste chirurgical \u00e9tait alors d\u00e9cid\u00e9 et une h\u00e9micolectomie gauche \u00e9tait r\u00e9alis\u00e9e accompagn\u00e9e de curage pr\u00e9 et interaorticocave. La pi\u00e8ce de r\u00e9section confirmait la nature ad\u00e9nocarcinomateuse moyennement diff\u00e9renci\u00e9e de la tumeur de type lieberkuhnien de stade PT3N0M0 (0 ganglion envahi sur 24). En revanche le curage ganglionnaire pr\u00e9 et inter-aorticocave montrait la prolif\u00e9ration d\u2019\u00e9l\u00e9ments lympho\u00efdes de petite taille avec en immunohistochimie une positivit\u00e9 pour le CD 20 et le CD 5 mais une n\u00e9gativit\u00e9 pour CD23, CD 10 et la cycline D1 permettait de diagnostiquer un lymphome lymphocytique B. Si les tests biologiques (h\u00e9mogramme, tests h\u00e9patiques, LDH, b\u00e9ta2 microglobuline, Coombs, s\u00e9rologie des h\u00e9patites et VIH) \u00e9taient normaux, la biopsie ost\u00e9o-m\u00e9dullaire montrait une infiltration lymphomateuse  et le TEP TDM au 18 FDG rapportait une hyperfixation ganglionnaire r\u00e9trop\u00e9riton\u00e9ale et coeliom\u00e9sent\u00e9rique. Le diagnostic de lymphome indolent \u00e9tait retenu ne justifiant qu\u2019une surveillance clinique, biologique et radiologique simple.<\/p>\n<p>Ce cas illustre le probl\u00e8me de relations possibles entre les traitements immunosuppresseurs et l\u2019apparition de lymphomes. Le risque oncog\u00e9nique de tels traitements a \u00e9t\u00e9 soulign\u00e9 depuis longtemps mais son importance r\u00e9elle reste sujette \u00e0 discussion. Dans notre discussion nous nous attacherons d\u2019abord \u00e0 analyser la relation entre la polyarthrite et les n\u00e9oplasies en g\u00e9n\u00e9ral et ensuite \u00e0 discuter de l\u2019influence des traitements immunosuppresseurs  et plus particuli\u00e8rement des anti -TNF alpha sur l\u2019apparition des h\u00e9molymphopathies.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2009 Vincent Gilles (1), Faiza Khemissa-Akouz (1), Andr\u00e9-Jean Remy (1), St\u00e9phane Ollivier (1), Sofiane Dahmouni(1), Claire Scotto (2), Bernard Heran (1). (1) Service d\u2019H\u00e9patogastroent\u00e9rologie et de Canc\u00e9rologie Digestive (2) Service de Rhumatologie Centre Hospitalier de Perpignan Gastroent\u00e9rologie &#8211; \u00a02009-07-08 &#8211;\u00a0CO &#8211; ________________________________ Plusieurs d\u00e9sordres lymphoprolif\u00e9ratifs apparus chez les patients trait\u00e9s par immunosuppresseurs ont \u00e9t\u00e9 ces [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[4],"tags":[20],"class_list":["post-1878","post","type-post","status-publish","format-standard","hentry","category-gastroenterologie","tag-20"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ad\u00e9nocarcinome colique et ad\u00e9nopathies envahies : un cancer peut en cacher un autre ! \u00e0 propos d\u2019un cas de lymphome sous Adalimumab* - Abstracts des congr\u00e8s de l&#039;ANGH<\/title>\n<meta name=\"description\" content=\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ad\u00e9nocarcinome colique et ad\u00e9nopathies envahies : un cancer peut en cacher un autre ! \u00e0 propos d\u2019un cas de lymphome sous Adalimumab* - Abstracts des congr\u00e8s de l&#039;ANGH\" \/>\n<meta property=\"og:description\" content=\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\" \/>\n<meta property=\"og:url\" content=\"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/\" \/>\n<meta property=\"og:site_name\" content=\"Abstracts des congr\u00e8s de l&#039;ANGH\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ANGH-2136322560030484\/\" \/>\n<meta property=\"article:published_time\" content=\"2009-10-01T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-10-20T16:39:51+00:00\" \/>\n<meta name=\"author\" content=\"abstracts\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"abstracts\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/\"},\"author\":{\"name\":\"abstracts\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1\"},\"headline\":\"Ad\u00e9nocarcinome colique et ad\u00e9nopathies envahies : un cancer peut en cacher un autre ! \u00e0 propos d\u2019un cas de lymphome sous Adalimumab*\",\"datePublished\":\"2009-10-01T00:00:00+00:00\",\"dateModified\":\"2018-10-20T16:39:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/\"},\"wordCount\":514,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\"},\"keywords\":[\"2009\"],\"articleSection\":[\"Gastroenterologie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/\",\"url\":\"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/\",\"name\":\"Ad\u00e9nocarcinome colique et ad\u00e9nopathies envahies : un cancer peut en cacher un autre ! \u00e0 propos d\u2019un cas de lymphome sous Adalimumab* - Abstracts des congr\u00e8s de l&#039;ANGH\",\"isPartOf\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#website\"},\"datePublished\":\"2009-10-01T00:00:00+00:00\",\"dateModified\":\"2018-10-20T16:39:51+00:00\",\"description\":\"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study\",\"breadcrumb\":{\"@id\":\"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/angh.net\/abstracts\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ad\u00e9nocarcinome colique et ad\u00e9nopathies envahies : un cancer peut en cacher un autre ! \u00e0 propos d\u2019un cas de lymphome sous Adalimumab*\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/angh.net\/abstracts\/#website\",\"url\":\"https:\/\/angh.net\/abstracts\/\",\"name\":\"Abstracts des congr\u00e8s de l&#039;ANGH\",\"description\":\"Base de donn\u00e9es des abstracts du congr\u00e8s depuis 2003\",\"publisher\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/angh.net\/abstracts\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/angh.net\/abstracts\/#organization\",\"name\":\"ANGH\",\"url\":\"https:\/\/angh.net\/abstracts\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg\",\"contentUrl\":\"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg\",\"width\":48,\"height\":18,\"caption\":\"ANGH\"},\"image\":{\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ANGH-2136322560030484\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1\",\"name\":\"abstracts\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g\",\"caption\":\"abstracts\"},\"url\":\"https:\/\/angh.net\/abstracts\/author\/abstracts\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ad\u00e9nocarcinome colique et ad\u00e9nopathies envahies : un cancer peut en cacher un autre ! \u00e0 propos d\u2019un cas de lymphome sous Adalimumab* - Abstracts des congr\u00e8s de l&#039;ANGH","description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/","og_locale":"fr_FR","og_type":"article","og_title":"Ad\u00e9nocarcinome colique et ad\u00e9nopathies envahies : un cancer peut en cacher un autre ! \u00e0 propos d\u2019un cas de lymphome sous Adalimumab* - Abstracts des congr\u00e8s de l&#039;ANGH","og_description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","og_url":"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/","og_site_name":"Abstracts des congr\u00e8s de l&#039;ANGH","article_publisher":"https:\/\/www.facebook.com\/ANGH-2136322560030484\/","article_published_time":"2009-10-01T00:00:00+00:00","article_modified_time":"2018-10-20T16:39:51+00:00","author":"abstracts","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"abstracts","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/#article","isPartOf":{"@id":"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/"},"author":{"name":"abstracts","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1"},"headline":"Ad\u00e9nocarcinome colique et ad\u00e9nopathies envahies : un cancer peut en cacher un autre ! \u00e0 propos d\u2019un cas de lymphome sous Adalimumab*","datePublished":"2009-10-01T00:00:00+00:00","dateModified":"2018-10-20T16:39:51+00:00","mainEntityOfPage":{"@id":"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/"},"wordCount":514,"commentCount":0,"publisher":{"@id":"https:\/\/angh.net\/abstracts\/#organization"},"keywords":["2009"],"articleSection":["Gastroenterologie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/","url":"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/","name":"Ad\u00e9nocarcinome colique et ad\u00e9nopathies envahies : un cancer peut en cacher un autre ! \u00e0 propos d\u2019un cas de lymphome sous Adalimumab* - Abstracts des congr\u00e8s de l&#039;ANGH","isPartOf":{"@id":"https:\/\/angh.net\/abstracts\/#website"},"datePublished":"2009-10-01T00:00:00+00:00","dateModified":"2018-10-20T16:39:51+00:00","description":"ANGH R\u00e9sum\u00e9s congr\u00e8s H\u00e9patologie Gastroent\u00e9romogie Hepatology Gastroenterology Etudes cliniques Clinical study","breadcrumb":{"@id":"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/angh.net\/abstracts\/adenocarcinome-colique-et-adenopathies-envahies-un-cancer-peut-en-cacher-un-autre-a-propos-dun-cas-de-lymphome-sous-adalimumab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/angh.net\/abstracts\/"},{"@type":"ListItem","position":2,"name":"Ad\u00e9nocarcinome colique et ad\u00e9nopathies envahies : un cancer peut en cacher un autre ! \u00e0 propos d\u2019un cas de lymphome sous Adalimumab*"}]},{"@type":"WebSite","@id":"https:\/\/angh.net\/abstracts\/#website","url":"https:\/\/angh.net\/abstracts\/","name":"Abstracts des congr\u00e8s de l&#039;ANGH","description":"Base de donn\u00e9es des abstracts du congr\u00e8s depuis 2003","publisher":{"@id":"https:\/\/angh.net\/abstracts\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/angh.net\/abstracts\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/angh.net\/abstracts\/#organization","name":"ANGH","url":"https:\/\/angh.net\/abstracts\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/","url":"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg","contentUrl":"https:\/\/angh.net\/abstracts\/wp-content\/uploads\/sites\/2\/2018\/10\/logo_angh_2018_-48px.jpg","width":48,"height":18,"caption":"ANGH"},"image":{"@id":"https:\/\/angh.net\/abstracts\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ANGH-2136322560030484\/"]},{"@type":"Person","@id":"https:\/\/angh.net\/abstracts\/#\/schema\/person\/f532083854369dca4b9f509cfbad90e1","name":"abstracts","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2bb25d9cedd377e33f0ebc4fb5994a2f9d3e02f897704acdcc173c15b7c75253?s=96&d=mm&r=g","caption":"abstracts"},"url":"https:\/\/angh.net\/abstracts\/author\/abstracts\/"}]}},"_links":{"self":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts\/1878","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/comments?post=1878"}],"version-history":[{"count":0,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/posts\/1878\/revisions"}],"wp:attachment":[{"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/media?parent=1878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/categories?post=1878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/angh.net\/abstracts\/wp-json\/wp\/v2\/tags?post=1878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}